(Updated - November 3, 2023 4:40 AM EDT)

HSBC analyst Yifeng Liu upgraded Moderna (NASDAQ: MRNA) from Reduce to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Upgrades

Moderna (MRNA) downside has played out, HSBC raises ratingNovember 3, 2023 9:49 AM Deutsche Bank Downgrades Moderna (MRNA) to Sell, 'further negative revenue revisions pressure'November 2, 2023 8:43 AM Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fallNovember 2, 2023 7:52 AM Moderna (MRNA) drops after announcing a $3.1 billion charge, partially due to Covid writedownsNovember 2, 2023 6:58 AM Moderna reins in 2023 COVID vaccine forecast, shares tumbleNovember 2, 2023 6:47 AM Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues BeatNovember 2, 2023 6:36 AM Form 8-K Moderna, Inc. For: Nov 02November 2, 2023 6:34 AM Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates November 2, 2023 6:32 AM Moderna (MRNA) November weekly 76 straddle into quarter resultsNovember 2, 2023 4:51 AM Form 144 Moderna, Inc. Filed by: AFEYAN NOUBARNovember 1, 2023 4:04 PM Moderna (MRNA) call put ratio 1 call to put into quarter results and outlookNovember 1, 2023 10:31 AM Flagship Pioneering Launches Pioneering IntelligenceNovember 1, 2023 10:30 AM Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayNovember 1, 2023 6:20 AM Moderna (MRNA) November weekly 76 straddle into quarter results November 1, 2023 5:05 AM